TrialJournal of clinical hypertension (Greenwich, Conn.)2010

Efficacy and safety of irbesartan/HCTZ in severe hypertension according to cardiometabolic factors.

Stanley S Franklin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.